Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
99 Results for "
SAMS
" in MedChemExpress (MCE) Product Catalog:
Products (99)
99 Results for "SAMS" in MCE Product Catalog:
Cat. No.: HY-104009AR
CAS No.: 2245255-66-5
Research Areas:
GSK2807 Trifluoroacetate (Standard) is the analytical standard of GSK2807 Trifluoroacetate (HY-104009A). This product is intended for research and analytical applications. GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of SMYD3, with a Ki of 14 nM and an IC50 of 130 nM .
Cat. No.: HY-180816
CAS No.: 303969-88-2
Target:
Research Areas:
PRMT5-MTA-IN-7 (Compound 14) is a selective PRMT5-MTA inhibitor. PRMT5-MTA-IN-7 exhibits KD values of PRMT5-MTA-IN-7 for PRMT5-MTA and PRMT5-SAM of 236 nM and 2.84 μM respectively, and the IC50 values of 4.08 and 13.6 μM respectively. PRMT5-MTA-IN-7 can selectively inhibit the proliferation of MTAP-deficient cancer cells. PRMT5-MTA-IN-7 can be used for the study of colon cancer .
Cat. No.: HY-E71221
Target:
Research Areas:
α-D-Ribose 1-methylphosphonate 5-phosphate C-P-lyase (EC 4.7.1.1) can be isolated from Escherichia coli and involves the [4Fe-4S] cluster and S-adenosyl-L-methionine (SAM) radical.
Cat. No.: HY-P704383
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: MAT1A; Methionine Adenosyltransferase I, Alpha; Methionine Adenosyltransferase 1A; Methionine Adenosyltransferase 1; MAT-I/III; AdoMet Synthase 1; MATA1; MAT 1; S-Adenosylmethionine Synthase Isoform Type-1; S-Adenosylmethionine Synthetase; Methionine Adenosyltransferase I/III; Methionine Adenosyltransferase; SAMS1; AdoMet Synthetase 1; SAMS; AMS1; MAT
Species:
Human
Source:
E. coli
Cat. No.: HY-181333
CAS No.: 2653338-74-8
Target:
Research Areas:
PROTAC EZH2 Degrader-38 (Compound 17) is a EZH2 PROTAC degrader with an IC50 of 165.00 nM. PROTAC EZH2 Degrader-38 functionally inhibits the methyltransferase activity of EZH2 and competitively binds to the SAM-binding pocket of the EZH2 SET domain .
Cat. No.: HY-E71453E
Target:
Research Areas:
23S rRNA (adenosine-1067-2'-O)-methyltransferase (EC 2.1.1.230) is a methyltransferase that utilizes S-adenosylmethionine (SAM) as a methyl donor to methylate the 2'-hydroxyl group of the ribose at position A1067 of bacterial 23S rRNA, thereby conferring resistance to thiopeptide antibiotics.
Cat. No.: HY-125105
CAS No.: 178803-91-3
Target:
Research Areas:
DC-S100 is a potent SET7 inhibitor with an IC50 of 30.04 μM. DC-S100 binds to the cofactor (SAM) binding site of SET7 and forms hydrogen bonds and hydrophobic interactions with residues at this site. DC-S100 is applicable to biological studies of epigenetics and related diseases .
Cat. No.: HY-100846R
CAS No.: 1913252-04-6
Research Areas:
JQEZ5 (Standard) is the analytical standard of JQEZ5 (HY-100846). This product is intended for research and analytical applications. JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitively inhibits polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects .
Cat. No.: HY-180846
CAS No.: 3119375-08-2
Target:
Research Areas:
NT32 is a selective METTL13 stabilizer with a Kd value of 14 μM. NT32 could occupy both the SAM/SAH-binding pocket and the peptide substrate-binding site of METTL13 simultaneously. NT32 specifically targets and stabilizes METTL13. NT32 shows no inhibitory activity against non-small cell lung cancer .
Cat. No.: HY-185849
CAS No.: 2585194-96-1
Target:
Research Areas:
SETDB1-IN-1 is a SETDB1 inhibitor with an IC50 of 16 μM. SETDB1-IN-1 inhibits histone methyltransferase) activity via SAM-competitive and peptide-dependent mechanisms. SETDB1-IN-1 is applicable to research related to melanoma, lung cancer, liver cancer, breast cancer and prostate cancer .
Cat. No.: HY-182400
CAS No.: 2201065-84-9
Research Areas:
AGI-25696 is an orally active ethionine adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 97 nM. AGI-25696 reduces intracellular SAM levels in cancer cells. AGI-25696 inhibits tumor growth in mice bearing subcutaneous KP4 MTAP-null pancreatic xenografts. AGI-25696 can be used for the research of mtap-deleted pancreatic cancer .
Cat. No.: HY-179622
CAS No.: 3106086-17-0
Research Areas:
ZS34 is a potent, orally active, and selective MAT2A inhibitor with an IC50 of 13.7 nM, displaying minimal hERG and UGT1A1 liabilities. ZS34 selectively suppresses the growth of methylthioadenosine phosphorylase (MTAP)-deficient cancer cells by inhibiting SAM synthesis, reducing SDMA levels, and inducing DNA damage. ZS34 exhibits antitumor efficacy in a HCT116 MTAP -/- xenograft mouse model. ZS34 can be used for the research of MTAP-deficient cancer .
Cat. No.: HY-E71453C
Target:
Research Areas:
23S rRNA (adenine2503-C2)-methyltransferase (EC 2.1.1.192) contains a [4Fe-4S] cluster and belongs to the "radical AdoMet" (radical SAM) family. It employs a radical-based mechanism to methylate the adenosine residue using a CH? group derived from S-adenosyl-L-methionine, while retaining the hydrogen atom at the C-2 position of adenosine 2503 in the 23S rRNA.
Cat. No.: HY-182021
CAS No.: 3124204-81-2
Target:
Research Areas:
NNMT-IN-8 is a non-SAM-mimicking bisubstrate inhibitor and a selective methyltransferase NNMT inhibitor, with IC50 values of 0.0084 μM and 0.0085 μM against human NNMT, and an IC50 of 0.0072 μM against mouse NNMT. NNMT-IN-8 exhibits prominent renal distribution characteristics and moderate bioavailability in rodents. NNMT-IN-8 dose-dependently inhibits renal NNMT in renal fibrosis models, thereby exerting antifibrotic effects. NNMT-IN-8 can be used to investigate the mechanisms of renal fibrosis .
Cat. No.: HY-183568
Research Areas:
MAT2A-IN-26 is an orally active MAT2A inhibitor with a human IC50 of 17.53 nM. MAT2A-IN-26 inhibits the enzymatic activity of MAT2A, thereby reducing the levels of S-adenosylmethionine (SAM) and symmetric dimethylarginine (sDMA). MAT2A-IN-26 inhibits the proliferation of MTAP-deficient cancer cells and induces anti-tumor efficacy in xenograft models. MAT2A-IN-26 can be used in non-small cell lung cancer research .
Cat. No.: HY-184653
Target:
Research Areas:
MS3-123 is an orally active PRMT1 inhibitor (IC50 = 11.4 nM) that selectively targets the unique Cys119 residue within the SAM-binding pocket. MS3-123 covalently binds to PRMT1 through a time-dependent irreversible mechanism and exhibits high selectivity over other PRMT family members and other methyltransferases. MS3-123 inhibits breast cancer cell proliferation, migration and invasion, and induces cell cycle arrest and apoptosis. MS3-123 is useful for breast cancer research .
Cat. No.: HY-181963
ZINC-1000507824 is a non-covalent reversible RNA cytosine-5 methyltransferase NSUN2 inhibitor. ZINC-1000507824 targets the SAM cofactor binding pocket of NSUN2 and forms stable NSUN2-ligand complexes. ZINC-1000507824 destabilizes oncogenic mRNAs encoding PI3K/AKT and MAPK/ERK pathway components, attenuates growth signals, reduces proliferative drive, and restores therapy sensitivity in cancer cells. ZINC-1000507824 can be used for the research of NSUN2-driven malignancies .
Cat. No.: HY-P704777
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MAT2A; Methionine Adenosyltransferase 2; Methionine Adenosyltransferase 2A; AdoMet Synthase 2; MAT-II; MAT 2; MATA2; Methionine Adenosyltransferase II; S-Adenosylmethionine Synthase Isoform Type-2; Testicular Tissue Protein Li 121; MATII; S-Adenosylmethionine Synthase; SAMS2; AdoMet Synthetase 2; Methionine Adenosyltransferase II, Alpha; AMS2
Species:
Human
Source:
E. coli
Cat. No.: HY-179556
SARS-CoV-2 nsp14-IN-10 is a highly potent and selective NSP14 (IC50 = 0.34 µM) S-adenosylmethionine (SAM) binding pocket inhibitor. SARS-CoV-2 nsp14-IN-10 demonstrates robust antiviral activity against SARS-CoV-2. SARS-CoV-2 nsp14-IN-10 exhibits broad-spectrum activity against other betacoronaviruses and inhibits SARS-CoV-2 at the replication stage. SARS-CoV-2 nsp14-IN-10 suppresses viral translation and exhibits immunostimulatory effects. SARS-CoV-2 nsp14-IN-10 specifically reverses NSP14-mediated alterations inhost transcriptome. SARS-CoV-2 nsp14-IN-10 can be used for the study of SARS-CoV-2 .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
